Global Antiviral Therapeutics Markets & Technologies Report 2021-2030: A Novel Feature of this Report is the Use of Nanotechnology in Virology and its Potential


You May Also Like

Sun BioPharma, Inc. Provides a Business Update and Files Report for Q2 2018

First Patients Enrolled in Front-Line Combination Study of SBP-101 with Gemcitabine and nab-Paclitaxel for ...

Aviragen Therapeutics Reports First Quarter of Fiscal Year 2018 Financial Results

ATLANTA, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Aviragen Therapeutics, Inc. (NASDAQ:AVIR) today announced its ...